Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Alirocumab on Reverse Cholesterol Transport in Humans

NCT03014830 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03014830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03014830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Alirocumab on Reverse Cholesterol Transport in Humans
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
June 1, 2017
Completion date
July 30, 2018
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary heart disease